There is no official link established between BPC-157 and erectile dysfunction in peer-reviewed medical literature
However, the lack of withdrawal symptoms doesnt mean stopping is safethe real danger is the immediate return of your underlying clotting risk
10.1523/JNEUROSCI.21-24-09519.2001 216 von CoellnR.KglerS.BhrM.WellerM.DichgansJ.SchulzJ
BPC-157 may be worth exploring for: Men recovering from tendon, ligament, or muscle injuries Those experiencing chronic joint pain or inflammation Men on TRT who train intensely and want additional recovery support Individuals with gastrointestinal issues (gut inflammation, leaky gut, NSAID damage) Those interested in peptide therapy as part of a comprehensive wellness protocol Who Should Avoid BPC-157 Anyone with active cancer (BPC-157s angiogenic properties could theoretically promote tumor blood supply) Individuals allergic to any component of the peptide formulation Those unwilling to undergo medical supervision Anyone expecting BPC-157 to replace testosterone therapy for hypogonadism References Sikiric P, Seiwerth S, Rucman R, et al
Suited for glaucoma research, cauterization of two episcleral veins may produce a considerable elevation of intraocular pressure
Glutathione can lessen the symptoms, thus improving the quality of life of people suffering from symptoms of Parkinsons
